Evidence map›Paper›PMID 26354425›Full record

ArticleMolecular biology of the cell2015

Small-molecule agonists of mammalian Diaphanous-related (mDia) formins reveal an effective glioblastoma anti-invasion strategy.

Jessica D Arden, Kari I Lavik, Kaitlin A Rubinic, Nicolas Chiaia, Sadik A Khuder, Marthe J Howard, Andrea L Nestor-Kalinoski, Arthur S Alberts, Kathryn M Eisenmann

Abstract read
In one paragraph

Article in Molecular biology of the cell, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. The Role of Rho GTPases in Motility and Invasion of Glioblastoma Cells.Analytical cellular pathology (Amsterdam) · 2020
    Review
  8. PLEKHG5 is a novel prognostic biomarker in glioma patients.International journal of clinical oncology · 2019
    Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Jessica D ArdenDepartment of Biochemistry and Cancer Biology, University of Toledo Health Science Campus, Toledo, OH 43614.
Kari I LavikDepartment of Biochemistry and Cancer Biology, University of Toledo Health Science Campus, Toledo, OH 43614.
Kaitlin A RubinicDepartment of Biochemistry and Cancer Biology, University of Toledo Health Science Campus, Toledo, OH 43614.
Nicolas ChiaiaDepartment of Neurosciences, University of Toledo Health Science Campus, Toledo, OH 43614.
Sadik A KhuderDepartments of Medicine and Public Health and Homeland Security, University of Toledo Health Science Campus, Toledo, OH 43614.
Marthe J HowardDepartment of Neurosciences, University of Toledo Health Science Campus, Toledo, OH 43614.
Andrea L Nestor-KalinoskiDepartment of Surgery, University of Toledo Health Science Campus, Toledo, OH 43614.
Arthur S AlbertsLaboratory of Cell Structure and Signal Integration, Van Andel Research Institute, Grand Rapids, MI 49503.
Kathryn M EisenmannDepartment of Biochemistry and Cancer Biology, University of Toledo Health Science Campus, Toledo, OH 43614 Kathryn.eisenmann@utoledo.edu).
University of Toledo · USNational Institutes of Health · USVan Andel Institute · US

Funding

Mechanisms Driving Cortical Cytoskeleton Dynamics in Cancer Cell InvasionR01CA151632 · NCI · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI EISENMANN, KATHRYN M · 2010 to 2014
$1.5M
NCI NIH HHS R01 CA151632NCI NIH HHS R01CA151632
6 · The paper itself

Abstract

The extensive invasive capacity of glioblastoma (GBM) makes it resistant to surgery, radiotherapy, and chemotherapy and thus makes it lethal. In vivo, GBM invasion is mediated by Rho GTPases through unidentified downstream effectors. Mammalian Diaphanous (mDia) family formins are Rho-directed effectors that regulate the F-actin cytoskeleton to support tumor cell motility. Historically, anti-invasion strategies focused upon mDia inhibition, whereas activation remained unexplored. The recent development of small molecules directly inhibiting or activating mDia-driven F-actin assembly that supports motility allows for exploration of their role in GBM. We used the formin inhibitor SMIFH2 and mDia agonists IMM-01/-02 and mDia2-DAD peptides, which disrupt autoinhibition, to examine the roles of mDia inactivation versus activation in GBM cell migration and invasion in vitro and in an ex vivo brain slice invasion model. Inhibiting mDia suppressed directional migration and spheroid invasion while preserving intrinsic random migration. mDia agonism abrogated both random intrinsic and directional migration and halted U87 spheroid invasion in ex vivo brain slices. Thus mDia agonism is a superior GBM anti-invasion strategy. We conclude that formin agonism impedes the most dangerous GBM component-tumor spread into surrounding healthy tissue. Formin activation impairs novel aspects of transformed cells and informs the development of anti-GBM invasion strategies.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsBrain NeoplasmsCell Line, TumorCell MovementForminsGlioblastomaGolgi ApparatusHumansNeoplasm InvasivenessRatsSmall Molecule LibrariesSpheroids, CellularAdaptor Proteins, Signal TransducingDIAPH1 protein, humanForminsSmall Molecule Libraries

Identifiers

PMID26354425
PMCPMC4626057
OpenAlexW2317248635

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.